PRQR
Price
$1.48
Change
+$0.03 (+2.07%)
Updated
Apr 24, 02:40 PM (EDT)
Capitalization
152.56M
14 days until earnings call
WVE
Price
$6.79
Change
+$0.23 (+3.51%)
Updated
Apr 23 closing price
Capitalization
1.01B
14 days until earnings call
Ad is loading...

PRQR vs WVE

Header iconPRQR vs WVE Comparison
Open Charts PRQR vs WVEBanner chart's image
ProQR Therapeutics
Price$1.48
Change+$0.03 (+2.07%)
Volume$500
Capitalization152.56M
Wave Life Sciences
Price$6.79
Change+$0.23 (+3.51%)
Volume$1.95M
Capitalization1.01B
PRQR vs WVE Comparison Chart
Loading...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRQR vs. WVE commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRQR is a Buy and WVE is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (PRQR: $1.45 vs. WVE: $6.79)
Brand notoriety: PRQR and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRQR: 106% vs. WVE: 141%
Market capitalization -- PRQR: $152.56M vs. WVE: $1.01B
PRQR [@Biotechnology] is valued at $152.56M. WVE’s [@Biotechnology] market capitalization is $1.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRQR’s FA Score shows that 1 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).

  • PRQR’s FA Score: 1 green, 4 red.
  • WVE’s FA Score: 0 green, 5 red.
According to our system of comparison, PRQR is a better buy in the long-term than WVE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRQR’s TA Score shows that 4 TA indicator(s) are bullish while WVE’s TA Score has 5 bullish TA indicator(s).

  • PRQR’s TA Score: 4 bullish, 4 bearish.
  • WVE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, WVE is a better buy in the short-term than PRQR.

Price Growth

PRQR (@Biotechnology) experienced а +27.19% price change this week, while WVE (@Biotechnology) price change was +16.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

PRQR is expected to report earnings on Jul 31, 2025.

WVE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WVE($1.01B) has a higher market cap than PRQR($153M). WVE (-45.109) and PRQR (-45.283) have similar YTD gains . PRQR has higher annual earnings (EBITDA): -24.12M vs. WVE (-101.74M). WVE has more cash in the bank: 302M vs. PRQR (149M). PRQR has less debt than WVE: PRQR (17.2M) vs WVE (25.4M). WVE has higher revenues than PRQR: WVE (108M) vs PRQR (18.9M).
PRQRWVEPRQR / WVE
Capitalization153M1.01B15%
EBITDA-24.12M-101.74M24%
Gain YTD-45.283-45.109100%
P/E RatioN/AN/A-
Revenue18.9M108M18%
Total Cash149M302M49%
Total Debt17.2M25.4M68%
FUNDAMENTALS RATINGS
PRQR vs WVE: Fundamental Ratings
PRQR
WVE
OUTLOOK RATING
1..100
911
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9495
PRICE GROWTH RATING
1..100
9165
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRQR's Valuation (29) in the Biotechnology industry is in the same range as WVE (54). This means that PRQR’s stock grew similarly to WVE’s over the last 12 months.

PRQR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as WVE (100). This means that PRQR’s stock grew similarly to WVE’s over the last 12 months.

PRQR's SMR Rating (94) in the Biotechnology industry is in the same range as WVE (95). This means that PRQR’s stock grew similarly to WVE’s over the last 12 months.

WVE's Price Growth Rating (65) in the Biotechnology industry is in the same range as PRQR (91). This means that WVE’s stock grew similarly to PRQR’s over the last 12 months.

WVE's P/E Growth Rating (100) in the Biotechnology industry is in the same range as PRQR (100). This means that WVE’s stock grew similarly to PRQR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRQRWVE
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
76%
Declines
ODDS (%)
Bearish Trend 14 days ago
84%
Bearish Trend 17 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
PRQR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CCTRX11.38N/A
N/A
Columbia Small Cap Value II R
DFSVX40.86N/A
N/A
DFA US Small Cap Value I
KCVIX16.33N/A
N/A
Knights of Columbus Large Cap Value I
RAAIX9.39N/A
N/A
Altegris/AACA Opportunistic Real Estt I
BFGIX43.84N/A
N/A
Baron Focused Growth Institutional

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with KRRO. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
+7.41%
KRRO - PRQR
59%
Loosely correlated
+9.95%
ATNF - PRQR
57%
Loosely correlated
-2.16%
WVE - PRQR
56%
Loosely correlated
+3.51%
ENVB - PRQR
43%
Loosely correlated
+4.07%
RCKT - PRQR
34%
Loosely correlated
+2.44%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with PRQR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
+3.51%
PRQR - WVE
58%
Loosely correlated
+7.41%
KRRO - WVE
51%
Loosely correlated
+9.95%
ATNF - WVE
42%
Loosely correlated
-2.16%
KYMR - WVE
41%
Loosely correlated
+6.56%
TRDA - WVE
38%
Loosely correlated
N/A
More